168 related articles for article (PubMed ID: 23429937)
1. Metastatic lymph node CHIP expression is a potential prognostic marker for resected esophageal squamous cell carcinoma patients.
Wen J; Luo KJ; Hu Y; Yang H; Fu JH
Ann Surg Oncol; 2013 May; 20(5):1668-75. PubMed ID: 23429937
[TBL] [Abstract][Full Text] [Related]
2. The epithelial-mesenchymal transition phenotype of metastatic lymph nodes impacts the prognosis of esophageal squamous cell carcinoma patients.
Wen J; Luo KJ; Liu QW; Wang G; Zhang MF; Xie XY; Yang H; Fu JH; Hu Y
Oncotarget; 2016 Jun; 7(25):37581-37588. PubMed ID: 27147562
[TBL] [Abstract][Full Text] [Related]
3. Positive transforming growth factor-β activated kinase-1 expression has an unfavorable impact on survival in T3N1-3M0 esophageal squamous cell carcinomas.
Wen J; Hu Y; Luo KJ; Yang H; Zhang SS; Fu JH
Ann Thorac Surg; 2013 Jan; 95(1):285-90. PubMed ID: 23272845
[TBL] [Abstract][Full Text] [Related]
4. Clinical study on lymph node metastatic recurrence in patients with N0 esophageal squamous cell cancer.
Sun ZG; Wang Z
Dis Esophagus; 2011 Apr; 24(3):182-8. PubMed ID: 21073618
[TBL] [Abstract][Full Text] [Related]
5. Prognostic relevance of Id-1 expression in patients with resectable esophageal squamous cell carcinoma.
Luo KJ; Wen J; Xie X; Fu JH; Luo RZ; Wu QL; Hu Y
Ann Thorac Surg; 2012 May; 93(5):1682-8. PubMed ID: 22480390
[TBL] [Abstract][Full Text] [Related]
6. Caspase-3 expression in metastatic lymph nodes of esophageal squamous cell carcinoma is prognostic of survival.
Wang XS; Luo KJ; Bella AE; Bu SS; Wen J; Zhang SS; Hu Y
World J Gastroenterol; 2014 Apr; 20(15):4414-20. PubMed ID: 24764681
[TBL] [Abstract][Full Text] [Related]
7. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
Sakai M; Kato H; Sano A; Tanaka N; Inose T; Kimura H; Sohda M; Nakajima M; Kuwano H
Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase 6 expression in metastatic lymph nodes is a valuable prognostic marker for resected node-positive esophageal squamous cell cancer.
Xie X; Luo K; Li Y; Ling Y; Zhang S; Xie X; Wen J
Cancer Manag Res; 2018; 10():5451-5460. PubMed ID: 30519093
[TBL] [Abstract][Full Text] [Related]
9. Metastatic lymph node ratio demonstrates better prognostic stratification than pN staging in patients with esophageal squamous cell carcinoma after esophagectomy.
Zhang H; Liang H; Gao Y; Shang X; Gong L; Ma Z; Sun K; Tang P; Yu Z
Sci Rep; 2016 Dec; 6():38804. PubMed ID: 27941828
[TBL] [Abstract][Full Text] [Related]
10. Prognostic implications of
Kwon D; Yun JY; Keam B; Kim YT; Jeon YK
World J Gastroenterol; 2016 Nov; 22(44):9803-9812. PubMed ID: 27956804
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of high-mobility group A2: A novel independent indicator of poor prognosis in patients with esophageal squamous cell carcinoma.
Wei R; Shang Z; Leng J; Cui L
J Cancer Res Ther; 2016; 12(4):1291-1297. PubMed ID: 28169242
[TBL] [Abstract][Full Text] [Related]
12. CyclinD1, p53, E-cadherin, and VEGF discordant expression in paired regional metastatic lymph nodes of esophageal squamous cell carcinoma: a tissue array analysis.
Luo KJ; Hu Y; Wen J; Fu JH
J Surg Oncol; 2011 Sep; 104(3):236-43. PubMed ID: 21480261
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of the survival in patients after surgical resection of thoracic esophageal cancer].
Zhang HL; Liu RL; Shi YT; Wang ZC; Wang BH; Li YJ; Zhou LY; Ping YM
Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):541-5. PubMed ID: 19950705
[TBL] [Abstract][Full Text] [Related]
14. The impact of the number of occult metastatic lymph nodes on postoperative relapse of resectable esophageal cancer.
Morimoto J; Tanaka H; Ohira M; Kubo N; Muguruma K; Sakurai K; Yamashita Y; Maeda K; Sawada T; Hirakawa K
Dis Esophagus; 2014 Jan; 27(1):63-71. PubMed ID: 23480452
[TBL] [Abstract][Full Text] [Related]
15. Effects of neoadjuvant chemotherapy on primary tumor and lymph node metastasis in esophageal squamous cell carcinoma: additive association with prognosis.
Akita H; Doki Y; Yano M; Miyata H; Miyashiro I; Ohigashi H; Ishikawa O; Nishiyama A; Imaoka S
Dis Esophagus; 2009; 22(4):291-7. PubMed ID: 19021686
[TBL] [Abstract][Full Text] [Related]
16. [Expression and clinical significance of PI3K in esophageal squamous cell carcinoma].
Zhang Y; Liu YP; Du K; Wang H; Wang XL
Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):594-8. PubMed ID: 22325219
[TBL] [Abstract][Full Text] [Related]
17. Reduction rate of lymph node metastasis as a significant prognostic factor in esophageal cancer patients treated with neoadjuvant chemoradiation therapy.
Aiko S; Yoshizumi Y; Ishizuka T; Sakano T; Kumano I; Sugiura Y; Maehara T
Dis Esophagus; 2007; 20(2):94-101. PubMed ID: 17439591
[TBL] [Abstract][Full Text] [Related]
18. Gli1, a potential regulator of esophageal cancer stem cell, is identified as an independent adverse prognostic factor in esophageal squamous cell carcinoma.
Yang Z; Cui Y; Ni W; Kim S; Xuan Y
J Cancer Res Clin Oncol; 2017 Feb; 143(2):243-254. PubMed ID: 27680978
[TBL] [Abstract][Full Text] [Related]
19. [Lymphatic metastasis intensity of and lymphadenectomy for thoracic esophageal squamous cell carcinoma].
Lu ZM; Zhang H; Wang MH; Cui DH; Yang YQ; Huang HZ
Ai Zheng; 2006 May; 25(5):604-8. PubMed ID: 16687083
[TBL] [Abstract][Full Text] [Related]
20. [VEGF-C mRNA expression and its relationship with clinicopathological parameters in esophageal squamous cell carcinoma].
Pan XF; Bao GL; Fang WT; Chen WH
Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):437-40. PubMed ID: 19024518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]